Unbiased Analysis of Today's Healthcare Issues
That is the question considered by Wouters and Kuha (2024) in a recent Health Affairs article. The authors use IQVIA data between 1982 and 2024 on the timing of drug launches and estimate median delay times using a Kaplan Meier estimates. They find that: From the first launch globally, the median time to availability was…
When Interest Rates Go Low, Should Public Debt Go High? ROI for SDOH interventions. Consumption responses to sweetened beverage taxes. Do health care quality improvement policies work for all? “Provider respondents reported spending time equivalent of more than 100 000 full-time registered nurses per year on prior authorization. ”
One of the key benefits of the UK health system is that everyone has access to care. However, is care provided equally to all people? A paper by Matias et al. (2024) examines whether or not there are any inequalities in waiting times by socioeconomic status for women diagnosed with breast cancer in England and…
Recently, the Office of Management and Budget has released new procedures to assess government regulation (Circular A-4) and economic policies (Circular A-94). What is unique about this guidance is that it weights benefits and costs of new regulations and policies based on the income of the individuals impacted. The goal is to help reduce inequality.…
The time may be fast approaching. A paper by Goh et al. 2024 sampled 50 physicians and examined which was better: physicians alone, physicians with access to GPT-4, or GPT-4 alone. The primary outcome was how well each group diagnosed the case (i.e., diagnostic reasoning score). The authors found that: The median diagnostic reasoning score…
Paxlovid (nirmatrelvir-ritonavir) is effective at preventing hospitalization and death from COVID-19, but few people use it. A paper by SteelFisher et al. (2024) surveyed 1,430 American adults to find out why. Their survey revealed patients had a lack of awareness of the treatment as well as misinformation about the treatment (among those who were aware…
Tyler Cowen on the price of Ozempic. Problems with the OMB’s social welfare function. Link between alcohol and cancer. Disparities in the rural-urban life expectancy. Why will Part D plans “…move drugs that are selected for [MFP] negotiation into a higher cost-sharing tier”?
My FTI colleagues Mark Van Ert and Krunal Patel summarize some of the new quality measures that will be incorporated into the 2025 CMS Star Ratings that are used to evaluate Medicare Advantage (MA) plans. The CMS Star Ratings are very important as CMS payments to MA plans is expected to increase by 3.7% or…
This questions may be harder to answer than it may seem. While some physicians are fully independent, and others are full employees, other physicians can be affiliated with hospitals, without being hospital-employed. There are various approaches for measuring whether a physician is integrated within a hospital system: Basic TIN-based measure. The standard approach to identifying…
Out of more than 50 alternative payment models (APM) that CMS has implemented only six have shown statistically significant cost savings and only four of these met the requirements to be expanded in duration and scope. That is not my opinion, CMS itself states this. We all want higher quality at lower cost; so the…